Suppr超能文献

低HEAR评分用于识别无需肌钙蛋白检测、发生重大不良心脏事件风险极低的急诊科胸痛患者的外部验证。

External validation of a low HEAR score to identify emergency department chest pain patients at very low risk of major adverse cardiac events without troponin testing.

作者信息

O'Rielly Connor M, Andruchow James E, McRae Andrew D

机构信息

Department of Emergency Medicine, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Room 3E34, Calgary, AB, T2N 4Z6, Canada.

出版信息

CJEM. 2022 Jan;24(1):68-74. doi: 10.1007/s43678-021-00159-y. Epub 2021 Jul 17.

Abstract

BACKGROUND

The history, ECG, age, risk factor (HEAR) score has been proposed to identify patients at sufficiently low risk of acute coronary syndrome that they may not require troponin testing. The objective of this study was to externally validate a low HEAR score to identify emergency department (ED) patients with chest pain at very low risk of 30-day major adverse cardiac events (MACE).

METHODS

This was a secondary analysis of a prospective cohort of patients requiring troponin testing to rule out myocardial infarction (MI) in a large urban ED. HEAR scores were calculated in two cohorts: (1) patients with no known history of coronary artery disease (CAD); and (2) all eligible patients. The proportion of patients classified as very low risk, sensitivity, specificity, predictive values and likelihood ratios at each cut-off were quantified for index acute myocardial infarction (AMI) and 30-day MACE at HEAR = 0 and HEAR ≤ 1 thresholds.

RESULTS

Of the 1150 patients included in this study, 820 (71.3%) had no history of CAD, 97 (8.4%) had index AMI and 123 (10.7%) had 30-day MACE. In patients with no prior history of CAD, HEAR ≤ 1 identified 202 (24.6%) of patients as very low risk for 30-day MACE with 98.4% (95% CI 91.6-99.9%) sensitivity. Among all patients, HEAR ≤ 1 identified 202 (17.6%) patients as very low risk for 30-day MACE with 99.2% (95% CI 95.6-99.9%) sensitivity.

CONCLUSIONS

A HEAR score ≤ 1 can identify more than 17% of all patients as very low risk for index AMI and 30-day MACE and unlikely to benefit from troponin testing. Broad implementation of this strategy could lead to significant resource savings.

摘要

背景

有人提出采用病史、心电图、年龄、危险因素(HEAR)评分来识别急性冠状动脉综合征风险足够低、可能无需进行肌钙蛋白检测的患者。本研究的目的是对外验证低HEAR评分,以识别胸痛急诊患者30天主要不良心脏事件(MACE)风险极低的患者。

方法

这是对一个前瞻性队列的二次分析,该队列患者来自一个大型城市急诊科,需要进行肌钙蛋白检测以排除心肌梗死(MI)。在两个队列中计算HEAR评分:(1)无已知冠状动脉疾病(CAD)病史的患者;(2)所有符合条件的患者。在HEAR = 0和HEAR≤1阈值下,对各切点处被归类为极低风险的患者比例、敏感性、特异性、预测值和似然比进行量化,用于索引急性心肌梗死(AMI)和30天MACE。

结果

本研究纳入的1150例患者中,820例(71.3%)无CAD病史,97例(8.4%)发生索引AMI,123例(10.7%)发生30天MACE。在无CAD病史的患者中,HEAR≤1将202例(24.6%)患者识别为30天MACE极低风险患者,敏感性为98.4%(95%CI 91.6 - 99.9%)。在所有患者中,HEAR≤1将202例(17.6%)患者识别为30天MACE极低风险患者,敏感性为99.2%(95%CI 95.6 - 99.9%)。

结论

HEAR评分≤1可将超过17%的所有患者识别为索引AMI和30天MACE极低风险患者,不太可能从肌钙蛋白检测中获益。广泛实施该策略可显著节省资源。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验